HAVCR2 and neoplasm: In summary, our findings demonstrate that IL-2/S-15/Akti combination is preferred for the expansion of T cells for adoptive T cell transfer, as they promote the expansion of CD45RA−CCR7+ tumor infiltrating lymphocytes with high cytotoxic potential and down-regulating PD-1+Tim-3+ cells and regulatory T cells.